MYNULA
LIVE

Serial Number

99727080

Owner

Amgen Inc.

Attorney

Elsa D. Lemoine

Filing Date

Mar 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MYNULA Trademark

Serial Number: 99727080

MYNULA is a trademark filed by Amgen Inc. on March 26, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Amgen Inc. (19 trademarks)

One Amgen Center Drive
Thousand Oaks, CA 91320-1799

Entity Type: 03

Trademark Details

Filing Date

March 26, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases, blood diseases, bone and skeletal diseases, cancer, cardiovascular diseases, sleep apnea, central nervous system diseases, cluster headaches, coronavirus disease, and Crohn's disease; Pharmaceutical preparations for treating dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammatory diseases and disorders, kidney diseases, liver diseases, lupus, and mental disorders; Pharmaceutical preparations for treating metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative or neurological diseases and disorders, obesity, chronic weight management, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases; Pharmaceutical preparations

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 18, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 18, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2026 CNRT
ASSIGNED TO EXAMINER
May 14, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 26, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2026 NWOS
NEW APPLICATION ENTERED
Mar 26, 2026 NWAP